Open AccessCOVID-19 related secondary bacterial pneumonia ~Comparisons with influenza～
Author(s) -
Masafumi Seki
Publication year - 2022
Publication title -
medical research archives
Language(s) - English
Resource type - Journals
eISSN - 2375-1924
pISSN - 2375-1916
DOI - 10.18103/mra.v10i1.2678
Subject(s) - streptococcus pneumoniae , haemophilus influenzae , medicine , bacterial pneumonia , pneumonia , antimicrobial , staphylococcus aureus , klebsiella pneumonia , vaccination , antibiotics , microbiology and biotechnology , immunology , virology , biology , bacteria , genetics
The presence of secondary bacterial infection is important in viral infectious disease. Influenza is known to become more severe with secondary bacterial pneumonia in particular when the Streptococcus pneumoniae and Haemophilus influenzae are co-infected, but with COVID-19, there are thought to be few concomitant bacterial infections. However, mortality in COVID-19 patients also increases with secondary bacterial infections, mainly Staphylococcus aureus such as MRSA and Gram-negative bacilli, and vigilance is needed. Consequently, there is a rising trend in prescriptions for antibiotics, but more appropriate diagnosis and antimicrobial stewardship are needed to suppress antimicrobial resistance, and vaccination will be the key strategy to prevent the severe viral infections related with secondary bacterial infection.